News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Raffaele Colombo: Honored to discuss ADCs at the ENASymp24
Raffaele Colombo/X
Oct 25, 2024, 11:41

Raffaele Colombo: Honored to discuss ADCs at the ENASymp24

Raffaele Colombo shared a post by Sandra Misale, Assistant professor at Sidney Kimmel Comprehensive Cancer Center, on X, adding:

”Such an honor and a pleasure to discuss ADCs this morning at the ENASymp24 and share the stage with Paolo Tarantino, Barbara Pistilli, Giuseppe Curigliano.

A fantastic faculty representing Canada, the U.S., France, and Italy!

And a special thanks to Sandra Misale for taking photos during our talks!”

Raffaele Colombo

Quoting Sandra Misale’s post:

”Exciting plenary session ENASymp24: ADCs’ opportunities and challenges in cancer treatment. Amazing presentations by Raffaele Colombo, Paolo Tarantino, Barbara Pistilli, Giuseppe Curigliano.”

Sandra Misale

Raffaele Colombo, a leading figure in the pharmaceutical industry is the Associate Director of Medicinal Chemistry at Zymeworks Inc.. His leadership and scientific acumen drive the discovery and optimization of novel drug candidates and advancing the treatment landscape for various diseases.

Barbara Pistilli cancer cancer treatment ENASymp24 Giuseppe Curigliano OncoDaily Oncology Paolo Tarantino Raffaele Colombo Sandra Misale Sidney Kimmel Comprehensive Cancer Center
Special Coverage
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy